FAM
PCRX icon

Fred Alger Management’s Pacira BioSciences PCRX Stock Holding History

Fred Alger Management’s Portfolio PCRX Stock Details PCRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q2 		– Sell
-26,000
Closed -$990K – 546
2019
Q1 		$990K Buy
26,000
+13,000
+100% +$507K ﹤0.01% 334
2018
Q4 		$559K Sell
13,000
-47,279
-78% -$2.21M ﹤0.01% 347
2018
Q3 		$2.96M Buy
+60,279
New +$2.61M 0.01% 260
2017
Q2 		– Sell
-133,388
Closed -$6.08M – 567
2017
Q1 		$6.08M Sell
133,388
-3,666
-3% -$158K 0.03% 207
2016
Q4 		$4.43M Buy
137,054
+36,265
+36% +$1.21M 0.02% 191
2016
Q3 		$3.45M Sell
100,789
-98,229
-49% -$3.85M 0.02% 221
2016
Q2 		$6.71M Sell
199,018
-1,658,544
-89% -$81.5M 0.04% 190
2016
Q1 		$98.4M Buy
1,857,562
+1,079,877
+139% +$63.2M 0.5% 54
2015
Q4 		$59.7M Buy
777,685
+569,206
+273% +$32.2M 0.29% 83
2015
Q3 		$8.57M Sell
208,479
-31,552
-13% -$1.93M 0.05% 208
2015
Q2 		$17M Sell
240,031
-73,705
-23% -$5.8M 0.08% 164
2015
Q1 		$27.9M Sell
313,736
-58,359
-16% -$5.92M 0.13% 131
2014
Q4 		$33M Buy
372,095
+84,085
+29% +$7.95M 0.16% 118
2014
Q3 		$27.9M Buy
288,010
+149,717
+108% +$14.6M 0.14% 130
2014
Q2 		$12.7M Buy
+138,293
New +$10.5M 0.06% 243

Other funds holding PCRX

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
CCM
Consonance Capital Management New York $7.28M AUM 43.59% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $23.2B AUM 40.19% 1-Year Est. Return
FCM
Frontier Capital Management Boston, Massachusetts $10.7B AUM 67.78% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
Schroder Investment Management Group
Schroder Investment Management Group London, United Kingdom $141B AUM 34.18% 1-Year Est. Return
RSCM
Rock Springs Capital Management Baltimore, Maryland $2.05B AUM 161.37% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
SIMG
Stephens Investment Management Group Houston, Texas $9.33B AUM 56.1% 1-Year Est. Return

Fred Alger Management's PCRX Position: Q2 2019 in Review

Fred Alger Management sold out of Pacira BioSciences (PCRX) in Q2 2019, closing a stake of 26,000 shares — an estimated $990K sold.

Fred Alger Management first reported a position in PCRX in Q2 2014 and held it in 15 quarters. The position peaked at $98.4M in Q1 2016. 218 funds tracked by Wall St. Rank hold PCRX as of Q2 2019.

  • Fred Alger Management reported no remaining Pacira BioSciences position as of Q2 2019 after selling out during the quarter.
  • Fred Alger Management sold 26,000 Pacira BioSciences shares in Q2 2019, an estimated $990K.
  • Fred Alger Management first reported a position in Pacira BioSciences in Q2 2014 and held it in 15 quarters.
  • Fred Alger Management's Pacira BioSciences position peaked at $98.4M in Q1 2016.
  • 218 funds tracked by Wall St. Rank held Pacira BioSciences as of Q2 2019.

Based on Fred Alger Management's 13F filing for Q2 2019, filed 14 Aug 2019.